SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1 | 0.0% | 850 | 0.0% | 0.00% | – |
Q2 2023 | $1 | 0.0% | 850 | 0.0% | 0.00% | – |
Q1 2023 | $1 | -66.7% | 850 | 0.0% | 0.00% | – |
Q4 2022 | $3 | -99.9% | 850 | 0.0% | 0.00% | – |
Q3 2022 | $4,000 | -60.0% | 850 | -63.8% | 0.00% | – |
Q2 2022 | $10,000 | -28.6% | 2,350 | 0.0% | 0.00% | -100.0% |
Q1 2022 | $14,000 | -22.2% | 2,350 | -29.9% | 0.00% | 0.0% |
Q4 2021 | $18,000 | -21.7% | 3,350 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $23,000 | -23.3% | 3,350 | +21.8% | 0.00% | 0.0% |
Q2 2021 | $30,000 | -3.2% | 2,750 | -33.7% | 0.00% | -50.0% |
Q1 2021 | $31,000 | -26.2% | 4,150 | +31.7% | 0.00% | 0.0% |
Q4 2020 | $42,000 | +200.0% | 3,150 | +110.0% | 0.00% | +100.0% |
Q3 2020 | $14,000 | +7.7% | 1,500 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $13,000 | +30.0% | 1,500 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $10,000 | -23.1% | 1,500 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $13,000 | -7.1% | 1,500 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $14,000 | -12.5% | 1,500 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $16,000 | +14.3% | 1,500 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $14,000 | – | 1,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |